Details for New Drug Application (NDA): 062050
✉ Email this page to a colleague
NDA 062050 describes PFIZERPEN-A, which is a drug marketed by Pfizer and is included in three NDAs. Additional details are available on the PFIZERPEN-A profile page.
The generic ingredient in PFIZERPEN-A is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.
The generic ingredient in PFIZERPEN-A is penicillin g procaine. There are ninety-two drug master file entries for this compound. Additional details are available on the penicillin g procaine profile page.
Summary for 062050
| Tradename: | PFIZERPEN-A |
| Applicant: | Pfizer |
| Ingredient: | ampicillin/ampicillin trihydrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
